Key Evidence #1
observationalPublic scholarly dataCitation signal: 154
Inulin supplementation may improve some glycemic and antioxidant indices and decrease malondialdehyde levels in women with type 2 diabetes.
Tier-BPublic-ready6/12/2026
Inulin
Glucose and metabolic health markers is closer to a research marker, so it should be read separately from a directly felt benefit.
Representative tier calculated from paper evidence that passed the collection audit.
Papers analyzed
20
Caution signal
Low
Representative score
66.8
Glucose and metabolic health markersDigestion and gut comfortNutrient status markers
Main benefit evidence
The representative ingredient tier is calculated from these target-level evidence groups.
Glucose and metabolic health7 studiesTier-BGlucose and metabolic health markersFairly consistent positive signal in studiesResearch marker focusPatient-group studyThis card is closer to a measured biomarker or lab outcome than a directly felt user benefit.Closer to a research marker than a directly felt benefit.Open metrics>
Glucose and metabolic health
7 studiesTier-B
Glucose and metabolic health markers
Fairly consistent positive signal in studiesResearch marker focusPatient-group study
This card is closer to a measured biomarker or lab outcome than a directly felt user benefit.
Closer to a research marker than a directly felt benefit.
Open metrics
>Glucose and metabolic markers
No direct rate reported. Read direction and evidence strength together.
Evidence score
60.0
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Digestion and gut health6 studiesTier-BDigestion and gut comfortFairly consistent positive signal in studiesFelt benefit focusPatient-group studyPotential benefit studied in Digestion and gut health.Open metrics>
Digestion and gut health
6 studiesTier-B
Digestion and gut comfort
Fairly consistent positive signal in studiesFelt benefit focusPatient-group study
Potential benefit studied in Digestion and gut health.
Open metrics
>Digestion and gut comfort
No direct rate reported. Read direction and evidence strength together.
Evidence score
58.5
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Nutrient status5 studiesTier-BNutrient status markersFairly consistent positive signal in studiesResearch marker focusPatient-group studyThis card is closer to a measured biomarker or lab outcome than a directly felt user benefit.Closer to a research marker than a directly felt benefit.Open metrics>
Nutrient status
5 studiesTier-B
Nutrient status markers
Fairly consistent positive signal in studiesResearch marker focusPatient-group study
This card is closer to a measured biomarker or lab outcome than a directly felt user benefit.
Closer to a research marker than a directly felt benefit.
Open metrics
>Nutrient status and deficiency markers
No direct rate reported. Read direction and evidence strength together.
Evidence score
56.7
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Blood pressure and vascular health1 studiesTier-CBlood pressure and vascular health markersSome positive signal observedResearch marker focusPatient-group studyThis card is closer to a measured biomarker or lab outcome than a directly felt user benefit.Closer to a research marker than a directly felt benefit.Open metrics>
Blood pressure and vascular health
1 studiesTier-C
Blood pressure and vascular health markers
Some positive signal observedResearch marker focusPatient-group study
This card is closer to a measured biomarker or lab outcome than a directly felt user benefit.
Closer to a research marker than a directly felt benefit.
Open metrics
>Blood pressure and vascular markers
No direct rate reported. Read direction and evidence strength together.
Evidence score
44.0
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Immune and respiratory health1 studiesTier-CImmune and respiratory supportSome positive signal observedFelt benefit focusPatient-group studyPotential benefit studied in Immune and respiratory health.Open metrics>
Immune and respiratory health
1 studiesTier-C
Immune and respiratory support
Some positive signal observedFelt benefit focusPatient-group study
Potential benefit studied in Immune and respiratory health.
Open metrics
>Immune and respiratory support
No direct rate reported. Read direction and evidence strength together.
Evidence score
37.9
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Recent research
Updated This Month10 new papers
10 new papers were added in this period. No new risk signal was identified.
What's new
10 new papers were added.No new risk signal was identified.
Most notable recent finding
This is the most meaningful new study in the latest update.
Why it mattersIt ranked highest among the newly collected papers for this ingredient in the latest update.
View paperKey cautions to review
Standalone side-effect signals and combination cautions are listed separately.
Caution index
0.6
Caution band: Low
Caution signals
0
Side effects + combos + curated rules
Key precautions
No combination caution signal is clear enough to show right now. This does not guarantee safety.
Standalone side effects, combination cautions, and positive combos are separated below.
Side-effect and combination signals
No standalone side-effect or combination signal is currently clear enough to show from the collected papers. This does not mean there is no concern.
Evidence summaries
Paper IDs and full lists are private. Only study types and summaries are shown.
Key Evidence #2
observationalPublic scholarly dataCitation signal: 133
Inulin-enriched diet is able to promote weight loss in obese patients, the treatment efficiency being related to gut microbiota characteristics, supporting that both drug treatment and microbiota might be taken into account in personalized nutrition interventi
Key Evidence #3
observationalPublic scholarly dataCitation signal: 109
In conclusion, Orafti® Inulin was effective in volunteers with chronic constipation and significantly improved bowel function.
3 more summariesLimited representative sample by study type.>
Public scholarly dataCitation signal: 93
observationalEvidence supports that reasonable administration of ITF supplementation may have potential clinical value as an adjuvant therapy for prediabetes and T2DM management.
Public scholarly dataCitation signal: 85
observationalMedium chain fatty acids and p-cresol are identified as differentiating metabolites toward Crohn’s disease status and as compared with HCs.
Public scholarly dataCitation signal: 84
observationalThe increased colonic delivery of propionate from IPE appears to attenuate this acetate‐mediated increase in intrahepatocellular lipid (IHCL), which may provide surplus lipogenic substrate to the liver in adults with non‐alcoholic fatty liver disease.
Inulin
arrow_backBack to listEvidence score: 66.8|Caution index: 0.6